hengrui glp-1 Hengrui, Kailera's oral clears late-stage bar in China but US results still pending GSK forges $12bn alliance with

Metformin is now increasingly being used in combination with new incretin-based therapies: glucagon-like peptide 1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors [46], both of which enhance pancreatic beta cell function

Thyroid diseases are considered the most commonly reported endocrine diseases in clinical practice, followed by lipid and carbohydrate disorders (7173)

Check with your doctor if you have blurred vision or any other changes in vision

Characteristics of GLP-1RAs GLP-1 receptor agonists (GLP-1RAs) have transformed the management of type 2 diabetes and obesity

Regarding HbA1c and HOMA-IR, there is a lack of sufficient evidence to reach any conclusion